Form D · Other
Pearl Health, Inc.
New York, NY · CIK 0001959488
Offering snapshot reported Dec 23, 2022 · SEC filing
- Reported sold
- $55.5M Offering amount: $55.5M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2022 | Initial | $55,500,001 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-468675
The Total Amount Sold includes $500,000 through the issuance of stock upon the conversion of outstanding convertible securities.
Source: Form D, filed Dec 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vineeta Agarwala | Director |
| Jeff De Flavio | Director |
| Michael Kopko | Director, Executive |
| Scott Kupor | Director |
| Kevin Ryan | Director |
Issuer details
Industry: Other (See others in industry)
Address:
220 Fifth Ave, 17th Floor
New York, NY, 10001
New York, NY, 10001